1,035
Participants
Start Date
December 31, 2004
Primary Completion Date
October 31, 2006
Study Completion Date
September 30, 2007
alitretinoin
Thomas Ruzicka, MD, Düsseldorf
Lead Sponsor
Basilea Pharmaceutica
INDUSTRY